The IVDR certification allows the company to pursue market expansion within Europe's in vitro diagnostic market.
Biomerica (BMRA) announces that its food intolerance products for Crohn’s Disease and Ulcerative Colitis have achieved CE-marking under the ...
Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union ...
Feb. 19, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced medical diagnostic solutions, is proud to announce that patients with Irritable Bowel Syndrome (IBS ...
IRVINE, Calif. - Biomerica, Inc. (NASDAQ:BMRA), a developer of medical diagnostic solutions, has achieved a significant regulatory milestone with the CE marking of its food intolerance products ...
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the ...
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results